Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
Public ClinicalTrials.gov record NCT00285766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Open-Label Study of the Safety, Tolerability and Efficacy of the Selegiline Transdermal System in Elderly Subjects With Major Depression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Objective of this 16-week, open-label study is to assess the safety and tolerability of once daily application of three doses of STS during continuous dosing in the treatment of elderly subjects with major depression. Subjects will have study visits (clinic visits) at beginning of study (baseline) and study weeks 1, 3, 5, 8, 12, and 16.
Study identification
- NCT ID
- NCT00285766
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2002
- Primary completion
- Not listed
- Completion
- Jun 30, 2005
- Last update posted
- Apr 21, 2008
2002 – 2005
United States locations
- U.S. sites
- 15
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mohammed Bari, M.D. | Chula Vista | California | 91910 | — |
| Charles Meredith, M.D. | San Diego | California | 92108 | — |
| Daniel Zimbroff, M.D. | Upland | California | 94589 | — |
| Kathleen Toups, M.D. | Walnut Creek | California | 94589 | — |
| Abbey Strauss, M.D. | Boynton Beach | Florida | 33437 | — |
| Barry Baumel, M.D. | Miami Beach | Florida | 33154 | — |
| Margarita Nunez, M.D. | St. Petersburg | Florida | 33702 | — |
| Mildred Farmer, M.D. | St. Petersburg | Florida | 33710 | — |
| Larry Eisner, M.D. | Tamarack | Florida | 33321 | — |
| Andrew Cutler, M.D. | Winter Park | Florida | 32789 | — |
| Robert Riesenberg, M.D. | Atlanta | Georgia | 30308 | — |
| James Hartford, M.D. | Florence | Kentucky | 41042 | — |
| Mitchel Kling, M.D. | Baltimore | Maryland | 21201 | — |
| Louise Beckett, M.D. | Oklahoma City | Oklahoma | 73103 | — |
| Penny Barnhart, M.D. | Wichita Falls | Texas | 76309 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00285766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2008 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00285766 live on ClinicalTrials.gov.